XBP1 and neoplasm: In conditional knockout mouse models with NK cell-specific deletion of either IRE1α or XBP1, experimental groups demonstrated significantly impaired tumor immunosurveillance compared to wild-type controls following intravenous challenge with B16F10 melanoma cells.